Victory Capital Management Portfolio holdings
AUM
$155B
1-Year Return
20.6%
This Quarter Return
-0.22%
1 Year Return
+20.6%
3 Year Return
+77.5%
5 Year Return
+161.59%
10 Year Return
+412.71%
AUM
$102B
AUM Growth
-$2.04B
(-2%)
Cap. Flow
-$1.15B
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
10.73%
Holding
2,911
New
181
Increased
1,145
Reduced
1,360
Closed
133
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$195M |
| 2 |
Newell Brands
NWL
|
+$186M |
| 3 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$146M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$131M |
| 5 |
Westlake Corp
WLK
|
+$104M |
Top Sells
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$235M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$235M |
| 3 |
AutoNation
AN
|
+$189M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$175M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$132M |
Sector Composition
| 1 | Technology | 17.67% |
| 2 | Industrials | 13.82% |
| 3 | Financials | 12.32% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Healthcare | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
NovoCure
NVCR
$1.37B
| $281K | ﹤0.01% |
2,420
-429,934
| -99% | -$49.9M |
|
2377
Goldman Sachs BDC
GSBD
$1.29B
| $280K | ﹤0.01% |
+15,262
| New | +$280K |
|
|
NVEE
2378
DELISTED
NV5 Global
NVEE
| $280K | ﹤0.01% |
11,368
+400
| +4% | +$9.85K |
|
2379
JFrog
FROG
$5.8B
| $279K | ﹤0.01% |
8,343
+681
| +9% | +$22.8K |
|
2380
Prothena Corp
PRTA
$447M
| $279K | ﹤0.01% |
+3,913
| New | +$279K |
|
|
PAE
2381
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $279K | ﹤0.01% |
46,644
+6,719
| +17% | +$40.2K |
|
|
SVC
2382
Service Properties Trust
SVC
$469M
| $277K | ﹤0.01% |
24,728
-1,243
| -5% | -$13.9K |
|
|
SPWR
2383
DELISTED
SunPower Corporation Common Stock
SPWR
| $276K | ﹤0.01% |
12,186
-5,643
| -32% | -$128K |
|
2384
Victory Capital Holdings
VCTR
$4.58B
| $275K | ﹤0.01% |
7,843
-2,040
| -21% | -$71.5K |
|
2385
Atea Pharmaceuticals
AVIR
$250M
| $274K | ﹤0.01% |
+7,823
| New | +$274K |
|
2386
Nektar Therapeutics
NKTR
$916M
| $272K | ﹤0.01% |
1,011
-4
| -0.4% | -$1.08K |
|
2387
Omega Flex
OFLX
$341M
| $272K | ﹤0.01% |
1,904
+226
| +13% | +$32.3K |
|
|
RWT
2388
Redwood Trust
RWT
$801M
| $272K | ﹤0.01% |
21,076
-704
| -3% | -$9.09K |
|
2389
Acadia Realty Trust
AKR
$2.54B
| $271K | ﹤0.01% |
13,265
-335
| -2% | -$6.84K |
|
2390
Rocket Pharmaceuticals
RCKT
$343M
| $271K | ﹤0.01% |
9,066
-324
| -3% | -$9.69K |
|
2391
Hayward Holdings
HAYW
$3.4B
| $270K | ﹤0.01% |
+12,133
| New | +$270K |
|
2392
Sinclair Inc
SBGI
$933M
| $269K | ﹤0.01% |
8,483
-419
| -5% | -$13.3K |
|
2393
Global Ship Lease
GSL
$1.11B
| $267K | ﹤0.01% |
+11,050
| New | +$267K |
|
2394
Jamf
JAMF
$1.3B
| $267K | ﹤0.01% |
6,941
-108
| -2% | -$4.15K |
|
2395
Franklin Covey
FC
$234M
| $264K | ﹤0.01% |
+6,466
| New | +$264K |
|
|
TWO
2396
Two Harbors Investment
TWO
$1.06B
| $264K | ﹤0.01% |
10,411
+192
| +2% | +$4.87K |
|
|
RVNC
2397
DELISTED
Revance Therapeutics, Inc.
RVNC
| $264K | ﹤0.01% |
9,482
-436
| -4% | -$12.1K |
|
2398
Relay Therapeutics
RLAY
$700M
| $263K | ﹤0.01% |
8,343
-776
| -9% | -$24.5K |
|
|
EDR
2399
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $262K | ﹤0.01% |
+9,131
| New | +$262K |
|
2400
Alto Ingredients
ALTO
$89M
| $261K | ﹤0.01% |
52,741
-32,139
| -38% | -$159K |
|